Piper Sandler analyst David Westenberg lowered the firm’s price target on Illumina to $290 from $300 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ILMN:
- Illumina downgraded to Hold at Argus on valuation, deteriorating outlook
- Illumina downgraded to Hold from Buy at Argus
- Illumina price target lowered to $300 from $330 at Canaccord
- Illumina to face EU fine of 10% of turnover due to Grail deal, Reuter says
- Illumina facing EU fine of 10% turnover over Grail deal, Reuters says